Loomis Sayles & Co. L P Sells 1,424,795 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Loomis Sayles & Co. L P cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 58.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,021,759 shares of the company's stock after selling 1,424,795 shares during the period. Loomis Sayles & Co. L P owned 0.60% of Option Care Health worth $31,981,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of OPCH. UMB Bank n.a. lifted its position in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock worth $26,000 after acquiring an additional 750 shares in the last quarter. GAMMA Investing LLC boosted its stake in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after purchasing an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. grew its holdings in Option Care Health by 3,362.8% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock valued at $47,000 after buying an additional 1,446 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Option Care Health by 14.8% in the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after acquiring an additional 377 shares during the period. Finally, International Assets Investment Management LLC grew its stake in Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock valued at $91,000 after acquiring an additional 2,757 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Trading Up 1.5 %

Shares of Option Care Health stock traded up $0.34 during trading on Tuesday, reaching $23.74. The company's stock had a trading volume of 2,203,366 shares, compared to its average volume of 1,544,258. The company has a market cap of $4.04 billion, a price-to-earnings ratio of 19.95, a PEG ratio of 2.39 and a beta of 1.32. The firm's 50-day moving average is $27.30 and its two-hundred day moving average is $29.00. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on OPCH shares. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an "outperform" rating on the stock in a report on Thursday, October 31st. Jefferies Financial Group cut Option Care Health from a "buy" rating to a "hold" rating and lowered their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a "buy" rating to a "neutral" rating and decreased their price objective for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial cut their price target on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating for the company in a research note on Friday, November 1st. Finally, JMP Securities raised their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research report on Monday, September 30th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $30.83.

Insider Activity

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares of the company's stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.